Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology

doi:10.12998/wjcc.v11.i27.6327

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 27

This Article

(148)

(149)

(0)

(17)

(1)

(5389)

(4)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Cases. Sep 26, 2023; 11(27): 6327-6343
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6327

Full Size Figure Download Figure

Figure 4 The protein-protein interaction network from the STRING database was visualized via Cytoscape software. The lines between two nodes represent the interaction. The darker the color of the node, the more relevant the relationship between them.

Citation: Ouyang JY, Lin WJ, Dong JM, Yang Y, Yang HK, Zhou ZL, Wang RQ. Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. World J Clin Cases 2023; 11(27): 6327-6343
URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6327.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6327

Ouyang JY, Lin WJ, Dong JM, Yang Y, Yang HK, Zhou ZL, Wang RQ. Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. World J Clin Cases 2023; 11(27): 6327-6343 [PMID: 37900230 DOI: 10.12998/wjcc.v11.i27.6327]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.